FdaApplication
NDA 020221
Identifiers
- fda_app_no: NDA020221
Properties
| Property | Value |
|---|---|
| applicant_name | LEGACY PHARMA INC SEZC |
| application_type | NDA |
| approval_date | 1995-12-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ETHYOL | AMIFOSTINE | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| ETHYOL | AMIFOSTINE | 375MG/VIAL | INJECTABLE;INJECTION |
2 products